← back to search

Zhifang Xu

Tianjin University of Traditional Chinese Medicine · CN
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Retinoids in leukemia and cellular processes.
h-index
22
citations
1,570
works
124
NIH funding
primary concept
email

Recent publications

Differential impact of IDH1/2 mutations on outcome in adult acute myeloid leukemia patients
Cancer Genetics 2025cited by 1position: middledoi
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche
Annals of Hematology 2024cited by 3position: middledoi
Human umbilical cord mesenchymal stem cells improve bone marrow hematopoiesis through regulation of bone marrow adipose tissue
Molecular and Cellular Biochemistry 2024cited by 3position: middledoi
Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
Discover Oncology 2023cited by 8position: middledoi
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro
Vox Sanguinis 2023cited by 8position: middledoi
A new pathway for the transformation of AML in MDS: APA mechanism regulated by NUDT21 and RUNX1
Neoplasma 2023cited by 1position: middledoi
TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling
Nature Communications 2022cited by 66position: middledoi
Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells
Molecular Cancer 2022cited by 45position: middledoi
Early platelet elevation after complete remission as a prognostic marker of favourable outcomes in favourable‐ and intermediate‐risk acute myeloid leukaemia: A retrospective study
Journal of Clinical Laboratory Analysis 2022cited by 3position: middledoi
The clinical characteristics and prognosis of cytogenetically normal AML with single mutations of <i>CEBPA</i>
International Journal of Laboratory Hematology 2021cited by 10position: middledoi
<i>GATA2</i> rs2335052 and <i>GATA2</i> rs78245253 single‐nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia
International Journal of Laboratory Hematology 2021cited by 4position: middledoi
The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with <i>CSF3R</i> mutations
International Journal of Laboratory Hematology 2021cited by 4position: middledoi
A lineage switch from <i>NPM1</i>‐mutant acute myeloid leukemia to acute T‐cell lymphoblastic leukemia with <i>KMT2D</i> and <i>ARID2</i> mutant
International Journal of Laboratory Hematology 2021cited by 3position: middledoi
Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression
Leukemia Research 2020cited by 14position: middledoi
T‐cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR‐ABL transcripts and t(10;11)(q11;p15)
Journal of Clinical Laboratory Analysis 2020cited by 5position: lastdoi
[Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
PubMed 2020cited by 2position: middledoi
Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study
Blood Cells Molecules and Diseases 2019cited by 22position: middledoi
Iron regulatory protein 2 deficiency may correlate with insulin resistance
Biochemical and Biophysical Research Communications 2019cited by 10position: middledoi
Droplet digital <scp>PCR</scp> for <scp>BCR</scp>/<scp>ABL</scp>(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression
European Journal Of Haematology 2018cited by 39position: middledoi
The <scp>CD</scp>9<sup>+</sup><scp>CD</scp>11b<sup>−</sup><scp>HLA</scp>‐<scp>DR</scp><sup>−</sup> immunophenotype can be used to diagnose acute promyelocytic leukemia
International Journal of Laboratory Hematology 2018cited by 17position: middledoi
Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia
Leukemia Research 2018cited by 13position: middledoi
TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes
Blood Cells Molecules and Diseases 2018cited by 8position: lastdoi
Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review
Oncology Letters 2018cited by 8position: middledoi
Identification of a novel fusion gene, <i>RUNX1‐PRPF38A</i>, in acute myeloid leukemia
International Journal of Laboratory Hematology 2017cited by 5position: middledoi
Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury
Cell Death and Disease 2016cited by 34position: middledoi
Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms
PLoS ONE 2015cited by 9position: middledoi
MDM4 Overexpressed in Acute Myeloid Leukemia Patients with Complex Karyotype and Wild-Type TP53
PLoS ONE 2014cited by 30position: middledoi
A New Isoprenylated Flavanone from Cajanus cajan
Chemistry of Natural Compounds 2014cited by 5position: middledoi
The short isoform of the long‐type <i><scp>PML</scp>‐<scp>RARA</scp></i> fusion gene in acute promyelocytic leukaemia lacks sensitivity to all‐trans‐retinoic acid
British Journal of Haematology 2013cited by 13position: middledoi
[Adult acute lymphoblastic leukemia with atypical BCR-ABL transcript e1a3: a case report and literature review].
PubMed 2013cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yanhong Tan · Shanxi Medical University24 papers (2012–2024)Xiuhua Chen · University of Florida21 papers (2012–2025)Hongwei Wang · Capital Medical University15 papers (2013–2023)Jianmei Chang · Shanxi Medical University11 papers (2015–2025)Fanggang Ren · Shanxi Medical University11 papers (2013–2021)Jing Xu · Sichuan University9 papers (2018–2025)Fanggang Ren · Shanxi Medical University7 papers (2013–2025)Yaofang Zhang · University of Nevada, Reno7 papers (2018–2025)Guoxia Li · Tianjin University of Traditional Chinese Medicine6 papers (2012–2021)Sicheng Bian · Case Western Reserve University4 papers (2012–2024)Jianlan Li · Jinan University4 papers (2015–2021)Daniel Muteb Muyey · Shanxi Medical University4 papers (2021–2023)Xiling Qi · Shanxi Medical University4 papers (2012–2017)Wanfang Yang · Shanxi Medical University3 papers (2015–2025)Haixiu Guo · Shanxi Medical University3 papers (2013–2015)Huanying Ren · Shanxi Medical University3 papers (2021–2024)Juan Xie · Nanchang University3 papers (2018–2020)Hongwei Wang · Nanjing Medical University3 papers (2012–2023)Fang Fang · Southwest University3 papers (2021–2021)Yi Chen · The First Affiliated Hospital, Sun Yat-sen University3 papers (2013–2021)